Testing Brain Scans That Show How Glioblastoma Uses Fuel
Original title: Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early first test of these scans in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests special scans that show how glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary tumors use sugar and other fuels.
Who this trial is for. It is for people with glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary that has not been treated yet, or that has come back. It tests two kinds of PET scans and a very strong MRI that look at how the tumor uses fuel.
Where it stands. The team will compare what the scans show with lab tests done on tumor tissue. They want to see if the scans match what the tissue shows. This trial has not reported results yet.
What this means, and what it doesn't
What it could mean: This study is about scans, not a new treatment. It may help doctors learn more about how these tumors work. If you think you fit, you could ask your care team about it.
What it doesn't mean: This is a test, not a proven scan or treatment. This study does not test a way to treat the tumor. Taking part does not promise any benefit to you. It is not a cure.
Source: ClinicalTrials.gov, September 9, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.